Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer.
Wang B, Liang Y, Wu Y, Li Q, Zeng Y, Liu L, Cao W, Geng X, Huang Y, Wu Y, Pan J, Zhang X, Gu JJ.
Wang B, et al. Among authors: liang y.
J Immunother Cancer. 2024 Nov 27;12(11):e009898. doi: 10.1136/jitc-2024-009898.
J Immunother Cancer. 2024.
PMID: 39608975
Clinical Trial.